Episode 120: AML Series, Pt 6 - AML Consolidation: Therapeutic Approaches
The Fellow on Call: The Heme/Onc Podcast
Understanding Cytogenetic Changes and Consolidation Therapy in AML
This chapter investigates the effects of cytogenetic abnormalities on relapse timing in patients receiving anthracyclines and alkylating agents. It also reviews historical consolidation therapies with cytarabine, emphasizing the significance of post-remission strategies and the challenges of dosing and toxicity.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
